Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto, Young‐Jun Park, Martina Beltramello, +22

Nature

Vaccine TargetImmunologyAntibody EngineeringMedicineCovid-19

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology

Luca Piccoli, Young‐Jun Park, M. Alejandra Tortorici, +47

Cell

Structure-guided High-resolution SerologyVirus StructureImmunodominant SitesImmunologyReceptor (Biochemistry) +3

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar, +256

Nature

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen, +53

Nature

VaccinationNeutralizing AntibodiesVaccine TargetHumoral ResponseImmunology +4

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen, Xianwen Zhang, James Brett Case, +29

Nature Medicine

N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2

Matthew McCallum, Anna De Marco, Florian A. Lempp, +31

Cell

Viral PathogenesisImmunologyVirologyViral Structural ProteinMedicine +1

Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies

Dami A. Collier, Anna De Marco, Isabella A.T.M. Ferreira, +18

Nature

VaccinationVaccine DevelopmentImmunologyVirologySars-cov-2 B.1.1.7 +2

Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Emma C. Thomson, Laura E. Rosen, James G. Shepherd, +63

Cell

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici, Martina Beltramello, Florian A. Lempp, +44

Science

Viral DiagnosticsImmunologyViral PathogenesisImmunodominanceImmunotherapeutics +16

SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

Tyler N. Starr, Nadine Czudnochowski, Zhuoming Liu, +54

Nature